Table 2.

Correlation between lipid levels and body mass index during pregnancy in women with gestational diabetes mellitus.

T1
Lipid	TC		TG					HDL				LDL					VLDL
Group	C	GDM	C			GDM		C		GDM		C		GDM			C		GDM
N° pairs	23	27	23			27		23		27		23		27			23		27
Spearman r	0.08	0.19	0.37			0.32		-0.04		-0.32		0.32		0.21			0.37		0.37
P	0.703	0.342	0.085			0.101		0.843		0.102		0.137		0.292			0.082		0.07
T2
Lipid	TC			TG					HDL				LDL					VLDL
Group	C	GDM		C	GDM				C		GDM		C		GDM			C	GDM
N° pairs	40	31		40	31				37		31		37		31			36	31
Spearman r	−0.01	−0.04		0.05	0.30				0.20		−0.02		−0.09		−0.07			−0.22	0.30
P	0.951	0.826		0.742	0.096				0.237		0.934		0.590		0.699			0.196	0.097
T3
Lipid	TC			TG					HDL				LDL					VLDL
Group	C	GDM		C			GDM		C		GDM		C			GDM		C		GDM
N° pairs	41	44		41			44		41		44		41			44		41		44
Spearman r	0.30	−0.17		−0.07			0.22		0.12		−0.09		−0.19			−0.18		−0.13		0.17
P	0.061	0.271		0.655			0.151		0.451		0.577		0.221			0.254		0.434		0.276

Control (C) women or women with gestational diabetes mellitus (GDM) were included. Spearman correlation analyses between body mass index (BMI) and lipid levels during the 1st trimester (T1, 0–14 weeks of gestation), 2nd trimester (T2, 14–28 weeks of gestation) or 3rd trimester (T3, 28–40 weeks of gestation) of pregnancy were performed. For each trimester, the following is shown: Group, pairs correlated, values for Spearman r and P. TC: total cholesterol, TG: triglycerides, HDL: high density lipoproteins, LDL: low density lipoproteins, VLDL: very low density lipoproteins. Significant differences were considered with p < 0.05.